Abstract
The COVID-19 pandemic has led to six million confirmed cases by May 31, 2020. We combined the number of monthly confirmed new cases and death with month, latitude, temperature, humidity, rainfall, and sunshine ultraviolet (UV) to explore the climate impact on epidemics in 116 countries and territories. There was a significant decrease in case-fatality rate (from 8.06% to 4.94%) and a significant increase in sunshine UV (from 46 to 68) in April and May. Humid subtropical climate regions had the most confirmed COVID-19 cases (24.4%). The fatality in temperate marine regions was the highest (11.6%). Case-weighted means of absolute latitude, monthly average maximum temperature, relative humidity, rainfall, and sunshine UV were 36.7 degrees, 20.5°C, 63%, 63mm, and 53.5, respectively. Monthly confirmed cases increase as the temperature, rainfall, and sunshine UV rise in cold region-months (r=0.34, 0.26, 0.26, respectively), but no correlation in hot region-months. The fatality was 7.44% in cold region-months (<20°C) but only 4.68% in hot region-months (≥20°C). The fatality was 7.14% in rainy region-months (≥40mm/month) but only 3.86% in rainless region-months (<40mm/month). The fatality was 7.40% in cloudy region-months (UV<50/day) but only 4.64% in sunny region-months (UV≥50/day). The overall fatality will continue to decrease, and the peak will go in the summer. It is wise to escape from an epicenter full of miasma to a hot sunny place in dry season without pollution.
- COVID-19
- Climate region
- Sunshine UV
- Temperature
- Relative humidity
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There was no funding source for this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
There is no ethics in this article.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data needed to evaluate the conclusion in the paper are present in the paper or the supplementary materials.
